Frazier Group
Frazier Group is a Series A to Series C stage investment firm. It has made 9 investments. They made 1 investment in the last 12 months. Their most common stage is series-a (56% of deals). Average disclosed round size is $160.7M (across 8 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CcAMPfield | Series A | $180M | Jun 2026 |
 cAMPfield Therapeutics | Series A | $180M | Jan 2026 |
 Paramify | Series A | $12M | Jan 2025 |
| KKizik | Series B | $20M | Jul 2022 |
 DocuSign | Unknown | $782M | Jan 2018 |
 Finsphere | Series A | $8M | Oct 2011 |
 Attovia Therapeutics | Series A | $60M | — |
 Xenoport | Series C | $43.9M | — |
 Socrata | Series C | — | — |
Top Co-Investors
Venrock3 shared
Longitude Capital2 shared
Forbion2 shared
Abingworth LLP2 shared
Deep Track Capital2 shared
Novo Capital2 shared
RA Capital Management2 shared
Mohr Davidow Ventures1 shared
SpringRock Ventures1 shared
Shasta Ventures1 shared
Vodafone Ventures1 shared
venBio1 shared
Illumina Ventures1 shared
Cormorant Asset Management1 shared
Frazier Life Sciences1 shared
GV1 shared
Ignition Partners1 shared
OrbiMed1 shared
Frazier Healthcare Partners1 shared
ARCH Venture Partners1 shared
Last updated: 20 October 2026